Med Device Online

Precise fluid control is fundamental to the performance of every microfluidic diagnostic device. This white paper explores the technologies behind integrated microfluidic pumping systems, showing how developers can replace bulky external pumps with compact, reliable solutions built directly into disposable cartridges and lab-on-a-chip platforms.

Effective reagent storage is one of the biggest challenges in developing scalable microfluidic cartridges for point-of-care and point-of-need diagnostics. This white paper explores practical approaches for storing both liquid and dry reagents while maintaining stability, simplifying manufacturing, and reducing costs without compromising assay performance.

Developing next-generation digital droplet technologies demands exceptional manufacturing precision, rapid design refinement, and scalable production methods. This customer success story highlights how Pattern Bioscience partnered with thinXXS to overcome these challenges while advancing single-cell microbiology solutions for bacterial infection analysis.

By Hiep X. Nguyen, DPharm, Ph.D., DTM, California Northstate University The pharmaceutical sector continues to pursue delivery methods that combine patient convenience with therapeutic efficacy.

By Eric Hinrichs, senior principal quality engineer (retired), Ethicon, part of the Johnson & Johnson Medical Device Companies In medical device development, document approvals seem to always be a roadblock when you are the most pressed for time. How much time do you have to take to explain the change to an approver? What about the frustration when an approver does not have a designated alternate? Why are there so many approvers for a simple change?

Software-enabled combination products demand early cross-functional alignment, regulatory foresight, and collaboration to avoid delays and accelerate patient access. Implementing Medium And High-Volume Drug Handling And Packaging Programs Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

Guest Column | July 8, 2026 By Mark F. Witcher, Ph.D., biopharma operations subject matter expert CDMOs are a vital part of the pharmaceutical and medical device industries. Building, executing, and maintaining an effective sponsor/CDMO working relationship is critical to developing, commercializing, and manufacturing many important therapies and products.

Are you ready? FDA has begun to implement the use of artificial intelligence in its operations, particularly during inspection activities. The Impact Of 3D Printing On Micro Molding — A Synergistic Approach Explore the future of micro manufacturing, where the convergence of micro molding and 3D printing promises to redefine what's possible in the creation of intricate, high-quality components.

The FDA has now completed just over 100 inspections under its new Quality Management System Regulation, and the agency has begun sharing preliminary observations from those inspections. FDA's complementary pilot could help weed through a persistent examination backlog, but uncertainty and upheaval in leadership at the top puts its future in question.

This article provides a framework to streamline the biological safety assessment process, reduce testing burdens, and improve patient safety for combination products. FM2 Range Of Non-Magnetic X7R Low Loss MLCCs The FM2 Non-Magnetic X7R Low Loss MLCCs deliver ultra-low ESR, high Q factor, and interference-free performance, ensuring superior reliability in MRI systems and high-frequency RF applications.